$590M for Bird Flu mRNA Vaccine: A Race Against Time Amidst Healthcare Crisis Fears
The Department of Health and Human Services (HHS) recently awarded Moderna a substantial $590 million grant to accelerate the development of an mRNA vaccine against avian influenza, specifically the H5N1 strain. This significant investment underscores the growing concern surrounding the potential for a widespread bird flu outbreak.
The high mortality rate associated with H5N1, particularly among elderly individuals and young children, is a major cause for alarm. Estimates suggest a mortality rate nearing 50% in these vulnerable populations, raising the specter of a severely strained healthcare system, especially considering the lingering effects of the COVID-19 pandemic on already overburdened hospitals, particularly in rural areas.… Continue reading
Matt Underwood 
John Q. Hosedrinker